Silverarc Capital Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Silverarc Capital Management’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-395,382	Closed	-$4.86M	–	108
2022 Q4	$4.86M	Buy	+395,382	New	+$9.42M	1.39%	25

Silverarc Capital Management's CINC Position: Q1 2023 in Review

Silverarc Capital Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 395,382 shares — an estimated $4.86M sold.

Silverarc Capital Management first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $4.86M in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Silverarc Capital Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Silverarc Capital Management sold 395,382 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $4.86M.
Silverarc Capital Management first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Silverarc Capital Management's CinCor Pharma, Inc. Common Stock position peaked at $4.86M in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Silverarc Capital Management's 13F filing for Q1 2023, filed 15 May 2023.